CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.3350
-0.0050 (-1.47%)
May 26, 2026, 3:56 PM EST
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $461.33 million as of May 27, 2026. Its market cap has decreased by -7.20% in one year.
Market Cap
461.33M
Enterprise Value
474.49M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.34
Market Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 461.33M, an increase of 8,230.87%. That is a compound annual growth rate of 24.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 461.33M | 29.72% |
| Dec 31, 2025 | 355.63M | 164.14% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 387.08M |
| Silence Therapeutics | 292.85M |
| Vaxart | 156.02M |
| Glorywin Entertainment Group | 149.60M |
| NDT Pharmaceuticals | 118.13M |
| HST Global | 117.39M |
| Sangamo Therapeutics | 72.21M |
| BioStem Technologies | 70.12M |